3rd Line GIST
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients (NCT01735968) | Novartis Pharmaceuticals | 2013-02-27 |
| A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients (NCT01468688) | Novartis Pharmaceuticals | 2012-04-20 |
Track 3rd Line GIST automatically
Every clearance here is in the API, with alerts when new ones post.